A patient at risk of suicide
53 results
1 - 53
Newer generation antidepressants for depressive disorders in children and adolescents
Pharmacological interventions for self‐harm in adults
Pharmacological interventions for self‐harm in adults
Lithium for maintenance treatment of mood disorders
Psychosocial interventions for preventing and treating depression in dialysis patients
Antidepressants for anorexia nervosa
Lithium versus antidepressants in the long‐term treatment of unipolar affective disorder
New generation antidepressants for depression in children and adolescents: a network meta‐analysis
Psychosocial interventions for self‐harm in adults
Interventions for preventing injuries in problem drinkers
Community mental health teams (CMHTs) for people with severe mental illnesses and disordered personality
Magnetic seizure therapy for treatment‐resistant depression
Interventions for self‐harm in children and adolescents
Amitriptyline for depression
Antiviral treatment for chronic hepatitis C in patients with human immunodeficiency virus
Antidepressants for treating depression in adults with end‐stage kidney disease treated with dialysis
Psychosocial interventions for self‐harm in adults
Interventions for self‐harm in children and adolescents
Combined pharmacotherapy and psychological therapies for post traumatic stress disorder (PTSD)
Antidepressants versus placebo for generalised anxiety disorder (GAD)
Haloperidol alone or in combination for acute mania
Selective serotonin reuptake inhibitors for fibromyalgia syndrome
Interventions for smoking cessation and reduction in individuals with schizophrenia
Hyperbaric oxygen therapy for the adjunctive treatment of traumatic brain injury
Psychological therapies for people with borderline personality disorder
Family intervention for schizophrenia
Interferon alpha for chronic hepatitis D
Routine use of patient reported outcome measures (PROMs) for improving treatment of common mental health disorders in adults
Baclofen for alcohol use disorder
Primary‐level worker interventions for the care of people living with mental disorders and distress in low‐ and middle‐income countries
Approaches for discontinuation versus continuation of long‐term antidepressant use for depressive and anxiety disorders in adults
Couple and family therapies for post‐traumatic stress disorder (PTSD)
Ketamine and other glutamate receptor modulators for depression in adults with bipolar disorder
Mirtazapine for fibromyalgia in adults
Psychological therapies for treatment‐resistant depression in adults
Intensive case management for severe mental illness
Neuromodulators for pain management in rheumatoid arthritis
Olanzapine IM or velotab for acutely disturbed/agitated people with suspected serious mental illnesses
Electroconvulsive therapy for schizophrenia
Antiepileptic drugs for chronic non‐cancer pain in children and adolescents


